FindTrial
Sign In

Preemptive ultrasound (USG) guided Erector spinae plane block (ESPB) as an adjuvant to general anesthesia for post operative pain relief for unilateral breast cancer surgeries : A comparison with preemptive intravenous tramadol

Observational study of preemptive ultrasound (USG) guided Erector spinae plane block (ESPB) or preemptive intravenous tramadol as adjuvants to general anesthesia for post operative pain relief in unilateral breast cancer surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059648
Enrollment
60
Registered
2023-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Ultrasound guided Erector spinae plane block: Ultrasound guided Erector spinae plane block is given at level of T1

Sponsors

Dr Dixit haizal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients posted for unilateral elective breast cancer surgery. -Patients belonging to ASA grade I, II or III. -Patient between age group 25 to 65 years -Patient giving informed written consent.

Exclusion criteria

Exclusion criteria: -Haemostatic abnormalities or on anticoagulant therapy. -Patients who are allergic to any of study drugs. -Skin infection at the site of needle insertion -Chronic pain syndromes or receiving chronic analgesic therapy. -Neuromuscular disease and established peripheral neuropathy. -Major cardio respiratory diseases and major hepatorenal disorders -Pregnancy

Design outcomes

Primary

MeasureTime frame
post operatively Decreased amount of opiod analgesic requirement for 48 hoursTimepoint: 48 hours—

Secondary

MeasureTime frame
1)Time duration to perform block & assessment of sensory block in ESPB patients 2)Intraoperative propofol requirement 3)Side effects/ adverse effects. Timepoint: 48 hours—

Countries

India

Contacts

Public ContactDr Bansari Kantharia

new civil hospital

Bansarikantharia@yahoo.com9825690177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026